Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses

BACKGROUND. There are limited data on the clinical benefits of adding surgical resection in patients with focally progressive gastrointestinal stromal tumor (GIST). This study aims to compare the clinical outcomes of resection plus imatinib dose escalation or maintenance (S group) with imatinib dose...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Cho, Hyungwoo, Ryu, Min‐Hee, Lee, Yongjune, Park, Young Soo, Kim, Ki‐Hun, Kim, Jwa Hoon, Park, Yangsoon, Lee, Sun Mi, Kim, Chan Wook, Kim, Beom Soo, Yoo, Moon‐Won, Kang, Yoon‐Koo
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2019
Ämnen:
Sarcomas
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6975948/
https://ncbi.nlm.nih.gov/pubmed/31315961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0009
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk